MEI Pharma Management

How experienced are the management team and are they aligned to shareholders interests?

3.7yrs

Average management tenure


CEO

Dan Gold (68 yo)

12.75yrs

Tenure

US$2,528,609

Compensation

Dr. Daniel P. Gold, also known as Dan, Ph D., has been the Chief Executive Officer and President of MEI Pharma, Inc. since April 26, 2010 and has been its Director since April 2010. Dr. Gold was responsibl...


CEO Compensation Analysis

How has Dan Gold's remuneration changed compared to MEI Pharma's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a

-US$54m

Jun 30 2022US$3mUS$717k

-US$54m

Mar 31 2022n/an/a

-US$47m

Dec 31 2021n/an/a

-US$64m

Sep 30 2021n/an/a

-US$60m

Jun 30 2021US$3mUS$683k

-US$41m

Mar 31 2021n/an/a

-US$53m

Dec 31 2020n/an/a

-US$31m

Sep 30 2020n/an/a

-US$43m

Jun 30 2020US$2mUS$650k

-US$47m

Mar 31 2020n/an/a

-US$24m

Dec 31 2019n/an/a

-US$38m

Sep 30 2019n/an/a

-US$5m

Jun 30 2019US$2mUS$610k

-US$17m

Mar 31 2019n/an/a

-US$39m

Dec 31 2018n/an/a

-US$28m

Sep 30 2018n/an/a

-US$46m

Jun 30 2018US$3mUS$592k

-US$40m

Mar 31 2018n/an/a

-US$25m

Dec 31 2017n/an/a

-US$20m

Sep 30 2017n/an/a

-US$2m

Jun 30 2017US$1mUS$575k

US$3m

Mar 31 2017n/an/a

US$1m

Dec 31 2016n/an/a

-US$4m

Sep 30 2016n/an/a

-US$21m

Jun 30 2016US$1mUS$552k

-US$21m

Compensation vs Market: Dan's total compensation ($USD2.53M) is above average for companies of similar size in the US market ($USD724.75K).

Compensation vs Earnings: Dan's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Daniel Gold
President12.75yrsUS$2.53m0.31%
$ 129.0k
Brian Drazba
CFO & Secretary5.75yrsUS$879.66k0.028%
$ 11.6k
David Urso
COO & General Counsel8.83yrsUS$1.74m0.037%
$ 15.2k
Richard Ghalie
Chief Medical Officer6.83yrsUS$1.16m0.022%
$ 8.9k
Eric Deng
Vice President of Technical Operations1.25yrsno datano data
Tina Beamon
Chief Compliance Officer1.5yrsno datano data
Eugene Park
Vice President of Marketing1yrno datano data
Anne Frese
Chief People Officer0.58yrno datano data
Robert Mass
Strategic Advisor11.58yrsUS$755.98k0.025%
$ 10.4k
Karen Potts
Senior Vice President of Regulatory Affairs8.25yrsno datano data
David Walsey
Senior Vice President of Corporate Affairs1.67yrsno datano data
Alejandro Ricart
Senior Vice President of Clinical Development1yrno datano data

3.7yrs

Average Tenure

62.5yo

Average Age

Experienced Management: MEIP's management team is considered experienced (3.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Daniel Gold
President12.75yrsUS$2.53m0.31%
$ 129.0k
Tamar Howson
Independent Non-Executive Director3.5yrsUS$144.60k0%
$ 0
Frederick Driscoll
Independent Non-Executive Director4.92yrsUS$152.10k0.028%
$ 11.6k
Nicholas Glover
Independent Non-Executive Director9.58yrsUS$154.16k0%
$ 0
Sujay Kango
Independent Director1.17yrsUS$124.85k0%
$ 0
Thomas Reynolds
Independent Non-Executive Director9.92yrsUS$144.60k0.0075%
$ 3.1k
Charles Baltic
Independent Non-Executive Director11.25yrsUS$152.10k0.022%
$ 9.2k

9.6yrs

Average Tenure

63yo

Average Age

Experienced Board: MEIP's board of directors are considered experienced (9.6 years average tenure).